Status:

WITHDRAWN

Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk Pregnancy

Lead Sponsor:

Fayoum University Hospital

Conditions:

High Risk Pregnancy

Eligibility:

FEMALE

25-35 years

Brief Summary

Anticoagulant therapy is indicated during pregnancy for the prevention and treatment of venous thromboembolism, systemic embolism in patients with mechanical heart valves and, in combination with aspi...

Detailed Description

Pregnancy is considered an acquired hypercoagulable state due to increased concentration of coagulation factors, decreased levels of anticoagulants and decreased fibrinolytic capacity. Adverse pregnan...

Eligibility Criteria

Inclusion

  • high-risk pregnant women (women with current preeclampsia, IUGR and oligohydramnios)
  • gestational age 28-37 weeks
  • no major medical illness contraindicating sildenafil use (cardiovascular disease, sickle cell anaemia, retinopathy, hearing loss, liver diseases)
  • willingness to sign informed consent for study randomization

Exclusion

  • gestational age less than 28 weeks
  • refusal of Doppler studies or sildenafil use
  • contraindication or allergy to sildenafil
  • those who can't present for monitoring visits or follow medication instructions
  • those with major medical illness including cardiovascular disease and diabetes mellitus
  • multiple pregnancies
  • suspected chromosomal or fetal congenital anomalies (documented by level II ultrasound examination)
  • users of any vasodilator agents
  • those who had maternal or fetal emergencies necessitating delivery at time of recruitment in the study or with diastolic blood pressure more than 110 mmHg
  • BMI is more than 34 that would impede accurate measurement of fetal biometry and Doppler parameters

Key Trial Info

Start Date :

January 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04110444

Start Date

January 1 2017

End Date

December 1 2023

Last Update

March 31 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

sahar M.Y elbaradie

Al Fayyum, Egypt